Presence & RecognitionEvent: September 7, 2026
uniQure presented safety data related to the Fabry genetherapy trial at SSIEM 2026 in Helsinki, Finland
Published
Signal category
Presence & Recognition
Quote
“uniQure’s Ari Pano and Christy Quintana presented updates on safety data related to our #Fabry #genetherapy trial”
— uniQure team
Company
uniQure
Transforming the lives of patients through gene therapy
- Industry
- Biotechnology Research
- Location
- Amsterdam, NL
- Company size
- 320 employees
uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with severe genetic diseases.
Founded 1998